Aligos Therapeutics Inc. buy me8
Start price
08.02.22
/
0%
€2.50
Target price
08.02.23
-
Performance (%)
-16.00%
End price
19.02.22
€2.10
Summary
This prediction ended on 19.02.22 with a price of €2.10. The prediction for Aligos Therapeutics Inc. disappointed with a performance of -16.00%. This prediction was marked as speculative and is excluded from me8's performance statistics.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Aligos Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -0.870% | -1.700% | 10.560% |
| iShares Nasdaq 100 | -5.561% | -3.604% | 34.335% |
| iShares Nikkei 225® | -6.138% | -7.732% | 16.215% |
| iShares S&P 500 | -3.141% | -2.011% | 24.534% |
According to me8 what are the pros and cons of Aligos Therapeutics Inc. for the foreseeable future?
Pros
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Capable Management
Cons
Bad culture
Comments by me8 for this prediction
In the thread Aligos Therapeutics Inc. diskutieren
Buy Aligos Therapeutics Inc.
In the thread Trading Aligos Therapeutics Inc.
Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.
Stopped prediction by me8 for Aligos Therapeutics Inc.
Aligos Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.37
15.05.23
15.05.23
-
15.05.24
15.05.24
-21.90%
27.05.23
27.05.23
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Aligos Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.54
25.01.22
25.01.22
€3.00
25.01.23
25.01.23
3.15%
05.02.22
05.02.22
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Capable Management
Bad culture
Aligos Therapeutics Inc.
Start price
Target price
Perf. (%)
€3.32
11.01.22
11.01.22
-
11.01.23
11.01.23
-21.08%
22.01.22
22.01.22
Differentiated customer and product portfolio
Could be worthwhile Investment >10% per year
Capable Management
Bad culture